{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:15:00Z","timestamp":1790036100709,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbmt.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T16:15:17Z","timestamp":1488471317000},"page":"958-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Marie","family":"Robin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryem","family":"Zine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Meignin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Munoz-Bongrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Moatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali\u00e9nor","family":"Xhaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Sicre de Fontbrune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Sarfati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.03.002_bib0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2141.1992.tb03004.x","article-title":"The role of the spleen after bone marrow transplantation for primary myelofibrosis","volume":"81","author":"Schmitz","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0015","first-page":"247","article-title":"Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia","volume":"5","author":"Helenglass","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood.V67.6.1693.1693","article-title":"Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation","volume":"67","author":"Rajantie","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.1989.tb06292.x","article-title":"Allogeneic bone marrow transplantation for primary myelofibrosis","volume":"71","author":"Dokal","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2141.1989.tb00306.x","article-title":"Allogeneic bone marrow transplantation for primary myelofibrosis","volume":"73","author":"Ifrah","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0035","first-page":"200","article-title":"Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction","volume":"7","author":"Barosi","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0040","first-page":"359","article-title":"Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases","volume":"36","author":"Lafaye","year":"1994","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0045","first-page":"3630","article-title":"Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia","volume":"91","author":"Barosi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0050","first-page":"2831","volume":"93","author":"Guardiola","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0055","first-page":"1615","article-title":"Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemia","volume":"10","author":"Richard","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2141.2010.08276.x","article-title":"Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis","volume":"150","author":"Robin","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0065","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1182\/blood-2009-07-234880","article-title":"Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"114","author":"Kr\u00f6ger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.2010.08417.x","article-title":"Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC)","volume":"152","author":"Robin","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0075","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1182\/blood-2010-06-293415","article-title":"Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis","volume":"116","author":"Passamonti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000421-199904000-00002","article-title":"Early postoperative complications of splenectomy for hematologic disease","volume":"22","author":"Arnoletti","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood.V122.21.306.306","article-title":"Ruxolitinib before allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in patients with myelofibrosis: a preliminary descriptive report of the JAK ALLO study, a phase II trial sponsored by Goelams-FIM in collaboration with the Sfgmtc (Abstract 306)","volume":"122","author":"Robin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0095","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbmt.2016.02.019","article-title":"Outcome after transplantation according to reduced-intensity conditioning regimen in patients undergoing transplantation for myelofibrosis","volume":"22","author":"Robin","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0100","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2014-04-572545","article-title":"MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis","volume":"124","author":"Rondelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/bmt.2009.188","article-title":"Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type","volume":"45","author":"Bacigalupo","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0110","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood-2014-02-558015","article-title":"JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bmt.2013.173","article-title":"Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib","volume":"49","author":"Jaekel","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.002_bib0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/1607845414Y.0000000192","article-title":"Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma","volume":"20","author":"Ishibashi","year":"2015","journal-title":"Hematology"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117303105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117303105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:09Z","timestamp":1761058689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117303105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1083879117303105"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}